Skip to Main Content

Paper Details

Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.
Leukemia
4
2019
Author NameAffiliation
Vilmarie RodriguezMayo Clinic
Maryalice Stetler-StevensonNational Cancer Institute
Maryalice Stetler-StevensonNational Cancer Institute
Claudia RossigUniversity Children's Hospital of Munster
Mignon L LohBenioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California San Francisco
  • 1 - 5

Datasets

Release 1.2